On behalf of the National Forum for Heart Disease and Stroke Prevention, Executive Director John Clymer presented comments to the Centers for Medicare and Medicaid Services (CMS) during a town hall on Medicare drug price negotiation for Janumet (sitagliptin and metformin). In his remarks, Clymer highlighted Janumet’s once-daily combination …
National Forum ED Addresses CMS on Medicare Drug Price Negotiation, Patient-Focused Town Hall for Tradjenta
On behalf of the National Forum for Heart Disease and Stroke Prevention, Executive Director John Clymer recently presented comments to the Centers for Medicare and Medicaid Services (CMS) during a town hall on Medicare drug price negotiation for Tradjenta (linagliptin). Clymer urged CMS to protect access to Tradjenta by emphasizing its distinct …
Mayors Nationwide to Kick Off Move with the Mayor® Mental Health Challenge on May 1
Mayors encourage residents to combine movement with connection to improve mental health This May, 51 mayors nationwide will inspire their communities to move, connect, and thrive. The Move with the Mayor® (MWTM) Mental Health and Physical Activity Challenge kicks off on May 1, with mayors inviting individuals to join a community-wide effort …
National Forum Urges OMB to Expand Access to Anti-Obesity Therapies
The National Forum for Heart Disease and Stroke Prevention presented comments to the Office of Management and Budget in support of expanding Medicare coverage for anti-obesity medications (AOMs). John Clymer, executive director of the National Forum, emphasized that obesity is a complex, chronic disease and urged policymakers to treat it as …
National Forum Urges Medicare Coverage for RDN to Treat Uncontrolled Hypertension
The National Forum for Heart Disease and Stroke Prevention submitted formal comments to the Centers for Medicare and Medicaid Services’ (CMS), supporting the national coverage analysis for renal denervation (RDN) as a treatment for uncontrolled hypertension. Hypertension is the leading cause of death and disability in the U.S., affecting …
National Forum Supports Expanded Access to Anti-Obesity Medications
The National Forum for Heart Disease and Stroke Prevention supports the Centers for Medicare and Medicaid Services’ proposal to recognize obesity as a chronic disease and expand Medicare and Medicaid coverage for anti-obesity medications (AOMs). This change aligns with the Treat and Reduce Obesity Act and addresses gaps in obesity care access, …
National Forum and Partners Call for Policy Changes to Expand Access to Pharmacist Care
Recommendations highlight the role of pharmacists in expanding access to care Washington, D.C. – The National Forum for Heart Disease and Stroke Prevention and a coalition of 14 organizations are urging policymakers to expand access to healthcare by fully utilizing pharmacists as integral members of the care team. In a joint policy …
National Forum Releases Policy Statement on Achieving Health, Fair Access to Care
Recommendations highlight the role of community health workers in bridging gaps in care Washington, D.C. – The National Forum for Heart Disease and Stroke Prevention and a coalition of 13 groups have issued a joint policy statement to promote health and fair access to care. The statement provides actionable recommendations for fully …
National Forum E.D. Applauds Proposed CMS Coverage for Anti-Obesity Meds, Urges Trump Administration to Finalize It
National Forum for Heart Disease & Stroke Prevention executive director John Clymer praised the Centers for Medicare and Medicaid Services (CMS) for proposing to expand coverage of anti-obesity medications (AOMs). Clymer also called on the incoming Trump Administration to finalize this initiative. CMS announced plans today to cover AOMs for …
